Martijn Schuemie
Martijn Schuemie
Janssen R&D
Verified email at ohdsi.org
Title
Cited by
Cited by
Year
Research on presence in virtual reality: A survey
MJ Schuemie, P Van Der Straaten, M Krijn, CAPG Van Der Mast
CyberPsychology & Behavior 4 (2), 183-201, 2001
8652001
Virtual reality treatment versus exposure in vivo: a comparative evaluation in acrophobia
PMG Emmelkamp, M Krijn, AM Hulsbosch, S De Vries, MJ Schuemie, ...
Behaviour research and therapy 40 (5), 509-516, 2002
5112002
Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers
G Hripcsak, JD Duke, NH Shah, CG Reich, V Huser, MJ Schuemie, ...
Studies in health technology and informatics 216, 574, 2015
4782015
Treatment of acrophobia in virtual reality: The role of immersion and presence
M Krijn, PMG Emmelkamp, R Biemond, CW de Ligny, MJ Schuemie, ...
Behaviour research and therapy 42 (2), 229-239, 2004
3802004
Overview of BioCreative II gene normalization
AA Morgan, Z Lu, X Wang, AM Cohen, J Fluck, P Ruch, A Divoli, K Fundel, ...
Genome biology 9 (2), 1-19, 2008
3532008
Combining electronic healthcare databases in Europe to allow for large‐scale drug safety monitoring: the EU‐ADR Project
PM Coloma, MJ Schuemie, G Trifiro, R Gini, R Herings, J Hippisley‐Cox, ...
Pharmacoepidemiology and drug safety 20 (1), 1-11, 2011
2832011
The incidence of narcolepsy in Europe: before, during, and after the influenza A (H1N1) pdm09 pandemic and vaccination campaigns
L Wijnans, C Lecomte, C de Vries, D Weibel, C Sammon, A Hviid, ...
Vaccine 31 (8), 1246-1254, 2013
2192013
Characterizing treatment pathways at scale using the OHDSI network
G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ...
Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016
1872016
Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study
A Arfè, L Scotti, C Varas-Lorenzo, F Nicotra, A Zambon, B Kollhorst, ...
bmj 354, 2016
1782016
A dictionary to identify small molecules and drugs in free text
KM Hettne, RH Stierum, MJ Schuemie, PJM Hendriksen, ...
Bioinformatics 25 (22), 2983-2991, 2009
1642009
Anni 2.0: a multipurpose text-mining tool for the life sciences
R Jelier, MJ Schuemie, A Veldhoven, LCJ Dorssers, G Jenster, JA Kors
Genome biology 9 (6), 1-10, 2008
1592008
Distribution of information in biomedical abstracts and full-text publications
MJ Schuemie, M Weeber, BJA Schijvenaars, EM van Mulligen, ...
Bioinformatics 20 (16), 2597-2604, 2004
1542004
Evaluating the impact of database heterogeneity on observational study results
D Madigan, PB Ryan, M Schuemie, PE Stang, JM Overhage, ...
American journal of epidemiology 178 (4), 645-651, 2013
1522013
Fear of flying treatment methods: virtual reality exposure vs. cognitive behavioral therapy
M Krijn, PMG Emmelkamp, RP Ólafsson, M Bouwman, LJ Van Gerwen, ...
Aviation, space, and environmental medicine 78 (2), 121-128, 2007
1382007
Interpreting observational studies: why empirical calibration is needed to correct p‐values
MJ Schuemie, PB Ryan, W DuMouchel, MA Suchard, D Madigan
Statistics in medicine 33 (2), 209-218, 2014
1252014
Risk of upper gastrointestinal bleeding from different drug combinations
GMC Masclee, VE Valkhoff, PM Coloma, M de Ridder, S Romio, ...
Gastroenterology 147 (4), 784-792. e9, 2014
1182014
Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?
G Trifirò, PM Coloma, PR Rijnbeek, S Romio, B Mosseveld, D Weibel, ...
Journal of internal medicine 275 (6), 551-561, 2014
1142014
Word sense disambiguation in the biomedical domain: an overview
MJ Schuemie, JA Kors, B Mons
Journal of Computational Biology 12 (5), 554-565, 2005
1142005
Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non‐SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 …
PB Ryan, JB Buse, MJ Schuemie, F DeFalco, Z Yuan, PE Stang, JA Berlin, ...
Diabetes, Obesity and Metabolism 20 (11), 2585-2597, 2018
1082018
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled …
JCE Lane, J Weaves, K Kostka, O Alser, A Prats-Uribe, D NEWBY, ...
MedRXiv, 2020
1072020
The system can't perform the operation now. Try again later.
Articles 1–20